Dvara Health Finance partners with IIHMR Bangalore

IMT News Desk
IMT News Desk
· 3 min read

The partnership will launch a diploma in community health and digital healthcare operations

Dvara Health Finance (DHF) and the Institute of Health Management Research (IIHMR), Bangalore, have signed a Memorandum of Understanding (MoU) to jointly develop and launch a Diploma in Community Health and Digital Healthcare Operations.

The pioneering programme is designed to train healthcare workers to bridge gaps between patients, digital health technologies, and licensed healthcare providers, particularly in rural and underserved areas.

The initiative supports the Ayushman Bharat Digital Mission (ABDM) by developing a workforce skilled in deploying point-of-care diagnostics, digital health records, and telemedicine—all critical to making healthcare more accessible, efficient, and patient-centric.

The 11-month diploma programme is structured into four competency-based levels:

  • Community Health Facilitator: Educating communities on preventive healthcare, hygiene, and digital health record creation.
  • Digital Health Technician: Conducting health screenings and managing digital patient data.
  • Digital Multipurpose Health Worker: Performing phlebotomy, handling imaging tools, and supporting diagnostics.
  • Community Health Leader: Leading public health campaigns, coordinating referrals, and improving community engagement.

With a strong practical and field-based training component, the programme ensures that graduates are equipped to strengthen primary healthcare services and improve health outcomes through digital tools and community-driven interventions.

Dvara Health Finance is actively working towards protecting Indian households from financial hardships arising from medical expenses. Through its NEEM offering, DHF provides access to trained health workers, a digital health platform, affordable medicines, and financial solutions that improve both financial and health outcomes.

DHF is currently piloting its model in Satara, Maharashtra, where its trained health workers—supported by digital tools—are enabling early detection and management of chronic conditions like diabetes and hypertension. By expanding its reach through this diploma programme, DHF aims to scale its impact and build a cadre of skilled health workers across India.

Bindu Ananth, Founder and CEO, Dvara Health Finance, said, “Given the rapid advances in digital health, the time is right for India to imagine a new cadre of community health workers – those that can combine patient empathy and proximity with technology versatility to use a range of screening, imaging and diagnostic tools. This will significantly close the gap in access to care, particularly for non-communicable diseases. We are delighted to partner with IIHMR Bangalore to realise this vision and look forward to partnering with many primary care providers as well.”

Dr Usha Manjunath, Director, IIHMR Bangalore, said, “The Diploma in Community Health and Digital Health Operations is a testament to IIHMR Bangalore’s commitment to bridging the gap between healthcare delivery and digital innovation. This programme not only equips participants with critical skills but also empowers them to drive transformative changes in community health systems. Together with Dvara Health Finance, we aim to nurture a new generation of the primary healthcare workforce prepared to address the challenges of tomorrow’s healthcare landscape with tech solutions.”

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk